These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31378636)

  • 41. Review article: the long-term use of proton-pump inhibitors.
    Raghunath AS; O'Morain C; McLoughlin RC
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():55-63. PubMed ID: 16042660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical efficacy of proton pump inhibitor therapy in neurologically impaired children with gastroesophageal reflux: prospective study.
    Cheung KM; Tse PW; Ko CH; Chan YC; Leung CY; Chan KH
    Hong Kong Med J; 2001 Dec; 7(4):356-9. PubMed ID: 11773669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of proton-pump inhibitors in a Hong Kong hospital.
    Lee VW; Yick PY; Yung GK; Tam KY
    Am J Health Syst Pharm; 2003 Aug; 60(16):1691. PubMed ID: 12966915
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention.
    Saini SD; Fendrick AM; Scheiman JM
    Aliment Pharmacol Ther; 2011 Jul; 34(2):243-51. PubMed ID: 21615437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton Pump Inhibitors and Dementia: Deciphering the Data.
    Moayyedi P; Lewis MA
    Am J Gastroenterol; 2017 Dec; 112(12):1809-1811. PubMed ID: 29215629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.
    Jalving M; Koornstra JJ; Wesseling J; Boezen HM; DE Jong S; Kleibeuker JH
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1341-8. PubMed ID: 17059515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Letter: cohort study examining the association between proton pump inhibitor therapy and risk of hepatocellular carcinoma in Taiwan.
    Liao KF; Lai HC; Lin CL; Lai SW
    Aliment Pharmacol Ther; 2018 Sep; 48(6):689-690. PubMed ID: 30132939
    [No Abstract]   [Full Text] [Related]  

  • 48. Proton pump inhibitors--differences emerge in hepatic metabolism.
    McColl KE; Kennerley P
    Dig Liver Dis; 2002 Jul; 34(7):461-7. PubMed ID: 12236477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review: Proton pump inhibitor-associated acute interstitial nephritis.
    Sierra F; Suarez M; Rey M; Vela MF
    Aliment Pharmacol Ther; 2007 Aug; 26(4):545-53. PubMed ID: 17661758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
    Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
    Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?
    Yeomans ND; Dent J
    Aliment Pharmacol Ther; 2000 Mar; 14(3):267-71. PubMed ID: 10735918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review article: appropriate use of proton pump inhibitors with traditional nonsteroidal anti-inflammatory drugs and COX-2 selective inhibitors.
    Kimmey MB; Lanas A
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():60-5. PubMed ID: 14725581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial: proton pump inhibition - microbial complications beyond dysbiosis.
    Hov JR
    Aliment Pharmacol Ther; 2019 Oct; 50(8):962-963. PubMed ID: 31591776
    [No Abstract]   [Full Text] [Related]  

  • 55. Appropriate Use of Proton Pump Inhibitors: A Double-Edged Sword.
    Lewis PO; Covert KL
    Am J Med; 2018 Mar; 131(3):218-219. PubMed ID: 29157650
    [No Abstract]   [Full Text] [Related]  

  • 56. Aspirin and proton-pump inhibitors: interpreting the interplay.
    Vaduganathan M; Bhatt DL
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):20-2. PubMed ID: 27533058
    [No Abstract]   [Full Text] [Related]  

  • 57. Association Between Proton Pump Inhibitor Use and Alzheimer's Disease in Older Adults.
    Liao KF; Chuang HY; Lai SW
    J Am Geriatr Soc; 2018 Sep; 66(9):1848-1850. PubMed ID: 30094831
    [No Abstract]   [Full Text] [Related]  

  • 58. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton pump inhibitors and suppression of duodenal eosinophilia in functional dyspepsia.
    Potter MDE; Wood NK; Walker MM; Jones MP; Talley NJ
    Gut; 2019 Jul; 68(7):1339-1340. PubMed ID: 29982192
    [No Abstract]   [Full Text] [Related]  

  • 60. Proton pump inhibitor and clopidogrel interaction: have we forgotten aspirin?
    Ali OH; Uzoigwe CE
    Br J Haematol; 2011 Nov; 155(3):407-8. PubMed ID: 21539532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.